FDA
- Status: approved
Ribavirin plus Xiao'er jiebiao oral liquid (Ribavirin plus Xiao'er jiebiao oral liquid) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Children's Hospital of Fudan University is the originator. The local marketing authorisation holder may differ — check the official source linked above.